|
DE2856393C2
(de)
*
|
1978-12-27 |
1983-04-28 |
Merz + Co GmbH & Co, 6000 Frankfurt |
Arzneimittel zur Behandlung von Morbus Parkinson
|
|
US5334618A
(en)
*
|
1991-04-04 |
1994-08-02 |
The Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
US5506231A
(en)
*
|
1989-03-31 |
1996-04-09 |
The Children's Medical Center Corporation |
Treatment of aids dementia, myelopathy and blindness
|
|
US5455279A
(en)
*
|
1991-04-19 |
1995-10-03 |
The Children's Medical Center Corporation |
Regimen method of mediating neuronal damage using nitroglycerine
|
|
WO1992017168A1
(fr)
*
|
1991-04-04 |
1992-10-15 |
The Children's Medical Center Corporation |
Procede permettant d'empecher les lesions neuronales dues aux recepteurs de n-methyl-d-aspartate
|
|
US5614560A
(en)
*
|
1991-04-04 |
1997-03-25 |
Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
DE4225730C2
(de)
*
|
1992-08-04 |
2003-04-30 |
Merz Pharma Gmbh & Co Kgaa |
Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
|
|
US6057373A
(en)
*
|
1997-05-22 |
2000-05-02 |
Synchroneuron, Llc |
Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
|
|
US5866585A
(en)
*
|
1997-05-22 |
1999-02-02 |
Synchroneuron, Llc |
Methods of treating tardive dyskinesia using NMDA receptor antagonists
|
|
US5952389A
(en)
*
|
1998-01-13 |
1999-09-14 |
Synchroneuron |
Methods of treating tardive dyskinesia and other movement disorders
|
|
US6294583B1
(en)
|
1998-01-13 |
2001-09-25 |
Synchroneuron, Llc |
Methods of treating tardive dyskinesia and other movement disorders
|
|
US6444702B1
(en)
|
2000-02-22 |
2002-09-03 |
Neuromolecular, Inc. |
Aminoadamantane derivatives as therapeutic agents
|
|
NZ531785A
(en)
*
|
2001-08-20 |
2007-03-30 |
Maiken Nedergaard |
Treatment of glial tumors with ionotropic glutamate receptor antagonists
|
|
EP1298581A1
(fr)
*
|
2001-09-27 |
2003-04-02 |
C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa |
Procédé et dispositif pour calculer les valeurs des neurones d'un réseau neuronal
|
|
AU2003274353B2
(en)
|
2002-10-24 |
2007-04-05 |
Merz Pharma Gmbh & Co. Kgaa |
Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
|
|
MXPA05012493A
(es)
|
2003-05-27 |
2006-05-25 |
Forest Laboratories |
Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo.
|
|
CN1240668C
(zh)
*
|
2003-09-10 |
2006-02-08 |
上海医药工业研究院 |
一种新的盐酸美金刚制备方法
|
|
ATE411015T1
(de)
*
|
2003-10-22 |
2008-10-15 |
Merz Pharma Gmbh & Co Kgaa |
Verwendung von 1-aminocyclohexan-derivaten zur modifizierung der abscheidung von fibrillogenen as peptiden in amyloidpathien
|
|
AR046314A1
(es)
|
2003-11-05 |
2005-11-30 |
Merz Pharma Gmbh & Co Kgaa |
Composiciones que comprenden ciclohexilaminas y aminoadamantanos
|
|
WO2005069742A2
(fr)
*
|
2003-12-10 |
2005-08-04 |
Sun Pharmaceutical Industries Limited |
Forme cristalline ii du chlorhydrate de memantine
|
|
DE602005024511D1
(de)
*
|
2004-01-05 |
2010-12-16 |
Merz Pharma Gmbh & Co Kgaa |
Memantin für die behandlung von leichtem bis mittelschwerem morbus alzheimer
|
|
CN100363329C
(zh)
*
|
2004-01-09 |
2008-01-23 |
南京大学 |
合成美金刚胺盐酸盐的方法
|
|
US7456224B2
(en)
*
|
2004-04-05 |
2008-11-25 |
Forest Laboratories Holdings, Ltd. |
Method for treating autism
|
|
US20060002999A1
(en)
*
|
2004-06-17 |
2006-01-05 |
Forest Laboratories, Inc. |
Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
|
|
CA2568445C
(fr)
|
2004-06-17 |
2011-05-24 |
Merz Pharma Gmbh & Co. Kgaa |
Formulations a liberation immediate de formes de dosage oral de memantine
|
|
EA011446B1
(ru)
*
|
2004-06-17 |
2009-02-27 |
Форест Лэборэтериз, Инк. |
Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
|
|
TW200616608A
(en)
*
|
2004-07-09 |
2006-06-01 |
Forest Laboratories |
Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
|
|
AU2005286672B2
(en)
*
|
2004-09-23 |
2009-03-12 |
Merz Pharma Gmbh & Co. Kgaa |
Memantine for the treatment of childhood behavioral disorders
|
|
US20060205822A1
(en)
*
|
2004-12-22 |
2006-09-14 |
Forest Laboratories, Inc. |
1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
|
|
ATE444950T1
(de)
*
|
2005-01-11 |
2009-10-15 |
Teva Pharm Fine Chemicals Srl |
Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
|
|
ITMI20050833A1
(it)
*
|
2005-05-10 |
2006-11-11 |
A M S A S P A Anonima Materie Sintetiche Affini |
Nuovo procedimento per la sintesi di aminoadamantani
|
|
EP1898890A1
(fr)
*
|
2005-06-16 |
2008-03-19 |
Forest Laboratories, Inc. |
Formulation de gouttes de memantine a liberation modifiee et immediate
|
|
US20070082940A1
(en)
|
2005-07-27 |
2007-04-12 |
Phil Skolnick |
Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
|
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
|
ES2379181T3
(es)
*
|
2006-02-21 |
2012-04-23 |
Hexal Ag |
Procedimiento para la preparación de adamantanaminas
|
|
ES2310504T1
(es)
*
|
2006-03-27 |
2009-01-16 |
Teva Pharmaceutical Fine Chemicals S.R.L. |
Procedimiento para la preparacion de clorhidrato de memantina sustancialmente libre de impurezas.
|
|
JP2010500288A
(ja)
|
2006-08-04 |
2010-01-07 |
メルツ・ファルマ・ゲーエムベーハー・ウント・コー・カーゲーアーアー |
置換ピラゾロピリミジン、それらの製造方法および医薬品としてのそれらの使用
|
|
EP1908748A1
(fr)
*
|
2006-10-05 |
2008-04-09 |
Krka |
Procédé de préparation de memantine et du chlorohydrate de memantine
|
|
WO2008063847A2
(fr)
*
|
2006-11-03 |
2008-05-29 |
Forest Laboratories Holdings Limited |
Méthode de traitement de l'autisme
|
|
MX2009006672A
(es)
|
2006-12-19 |
2009-10-26 |
Univ Virginia |
Efectos combinados de topiramato y ondansetron sobre el consumo de alcohol.
|
|
US7964613B2
(en)
|
2007-02-28 |
2011-06-21 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
|
WO2008153937A2
(fr)
|
2007-06-06 |
2008-12-18 |
Dov Pharmaceutical, Inc. |
Nouveaux 1- hétéroaryl-3-azabicyclo[3.1.0]hexanes, leurs méthodes de préparation et leur utilisation comme médicaments
|
|
US9133159B2
(en)
|
2007-06-06 |
2015-09-15 |
Neurovance, Inc. |
1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
|
|
GB0713930D0
(en)
|
2007-07-18 |
2007-08-29 |
Generics Uk Ltd |
Novel assay methods
|
|
EP2090576A1
(fr)
|
2008-02-01 |
2009-08-19 |
Merz Pharma GmbH & Co.KGaA |
6-halo-pyrazolo[1,5-a]pyridines, leur procédé de préparation et leur utilisation en tant que modulateurs des récepteurs metabotropiques du glutamate (mGluR)
|
|
EP2085398A1
(fr)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, leur procédé de préparation et leur utilisation en tant que médicament
|
|
US20090247644A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Forest Laboratories Holdings Limited |
Memantine formulations
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
EP2111858A1
(fr)
|
2008-04-25 |
2009-10-28 |
EPFL Ecole Polytechnique Fédérale de Lausanne |
Nouveau traitement pour la maladie d'Alzheimer
|
|
US20090275597A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Forest Laboratories Holdings Limited |
Methods of treating cns disorders
|
|
EP2138173A1
(fr)
|
2008-06-26 |
2009-12-30 |
Merz Pharma GmbH & Co.KGaA |
Compositions pharmaceutiques comportant des dérivés d'aminoadamantane
|
|
JP5195256B2
(ja)
*
|
2008-10-10 |
2013-05-08 |
東ソー株式会社 |
アミノアダマンタン誘導体の製造方法
|
|
HRP20090186A2
(hr)
|
2009-03-31 |
2010-10-31 |
Institut Ruđer Bošković |
Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona
|
|
WO2010112221A1
(fr)
|
2009-04-03 |
2010-10-07 |
Synthon B.V. |
Compositions pharmaceutiques renfermant de la mémantine
|
|
CN102070463A
(zh)
*
|
2009-06-11 |
2011-05-25 |
辽宁利锋科技开发有限公司 |
具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用
|
|
TW201116532A
(en)
|
2009-08-05 |
2011-05-16 |
Merz Pharma Gmbh & Co Kgaa |
Metabotropic glutamate receptor modulators
|
|
MX2012006320A
(es)
|
2009-12-02 |
2013-01-18 |
Adamas Pharmaceuticals Inc |
Composiciones de amantadina y metodos para su uso.
|
|
US20110251239A1
(en)
|
2010-04-07 |
2011-10-13 |
Eisai Inc. |
Combination therapy for the treatment of dementia
|
|
AR083475A1
(es)
|
2010-10-18 |
2013-02-27 |
Merz Pharma Gmbh & Co Kgaa |
Moduladores de receptores de glutamato metabotropicos
|
|
CN103282349A
(zh)
|
2010-10-29 |
2013-09-04 |
德国麦氏大药厂 |
吲哚衍生物及其制备方法
|
|
WO2012068161A1
(fr)
|
2010-11-15 |
2012-05-24 |
Agenebio, Inc. |
Dérivés de pyridazine, compositions et méthodes de traitement d'une déficience cognitive
|
|
WO2012085166A1
(fr)
|
2010-12-22 |
2012-06-28 |
Merz Pharma Gmbh & Co. Kgaa |
Modulateurs des récepteurs glutamatergiques métabotropes
|
|
AR084515A1
(es)
|
2010-12-22 |
2013-05-22 |
Merz Pharma Gmbh & Co Kgaa |
Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
|
|
CN102241678B
(zh)
|
2011-04-26 |
2014-10-29 |
辽宁利锋科技开发有限公司 |
含有脂环结构化合物的抗肿瘤作用与应用
|
|
WO2012152854A1
(fr)
|
2011-05-12 |
2012-11-15 |
Merz Pharma Gmbh & Co. Kgaa |
Modulateurs de récepteur de glutamate métabotropique
|
|
WO2012172093A1
(fr)
|
2011-06-17 |
2012-12-20 |
Merz Pharma Gmbh & Co. Kgaa |
Dérivé de dihydroindolizine à titre de modulateurs des récepteurs métabotropes de glutamate
|
|
CN103288650B
(zh)
*
|
2012-02-28 |
2015-09-30 |
广州白云山制药股份有限公司广州白云山制药总厂 |
一种盐酸1-氨基-3,5-二甲基金刚烷的制备方法
|
|
EP2650284A1
(fr)
|
2012-04-10 |
2013-10-16 |
Merz Pharma GmbH & Co. KGaA |
Dérivés hétérocycliques comme modulateurs de récepteurs du glutamate métabotropique
|
|
RU2488388C1
(ru)
|
2012-05-24 |
2013-07-27 |
Ооо "Валента Интеллект" |
Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
|
|
WO2014204933A1
(fr)
|
2013-06-17 |
2014-12-24 |
Adamas Pharmaceuticals, Inc. |
Compositions d'amantadine et procédés d'utilisation
|
|
US9566264B2
(en)
|
2013-07-01 |
2017-02-14 |
Euthymics Bioscience, Inc. |
Combinations and methods
|
|
CN112409363B
(zh)
|
2013-12-20 |
2023-11-14 |
艾吉因生物股份有限公司 |
用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
|
|
JP6604957B2
(ja)
|
2014-02-04 |
2019-11-13 |
フォレスト・ラボラトリーズ・ホールディングス・リミテッド |
ドネペジル組成物及びアルツハイマー病を治療する方法
|
|
JP6987384B2
(ja)
|
2015-06-19 |
2021-12-22 |
エージンバイオ， インコーポレイテッド |
ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
|
|
JP6354701B2
(ja)
*
|
2015-08-19 |
2018-07-11 |
大日本印刷株式会社 |
高純度メマンチン塩酸塩の製造法
|
|
JP7174632B2
(ja)
|
2016-06-23 |
2022-11-17 |
コリウム， インコーポレイテッド |
親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
|
|
AU2017301929B2
(en)
|
2016-07-27 |
2023-03-02 |
Corium Pharma Solutions, Inc. |
Memantine transdermal delivery systems
|
|
AU2017302305A1
(en)
|
2016-07-27 |
2019-02-14 |
Corium, LLC. |
Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
|
|
CA3031945A1
(fr)
|
2016-07-27 |
2018-02-01 |
Corium International, Inc. |
Formulation transdermique et procede d'administration d'un medicament de forme neutre non ionise de faible solubilite ou instable par conversion sel de medicament sur place d'un m edicament de forme neutre a forme sel
|
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
BR112019012821A2
(pt)
|
2016-12-19 |
2019-11-26 |
Agenebio Inc |
derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
|
|
US10369187B2
(en)
|
2017-02-09 |
2019-08-06 |
Vanderbilt University |
Peptide regulators of JNK family kinases
|
|
JP2019094304A
(ja)
*
|
2017-11-27 |
2019-06-20 |
学校法人順天堂 |
オートファジー誘導剤
|
|
AU2018392686A1
(en)
|
2017-12-20 |
2020-07-09 |
Corium Pharma Solutions, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
|
US11414425B2
(en)
|
2018-06-19 |
2022-08-16 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
WO2021232232A1
(fr)
*
|
2020-05-19 |
2021-11-25 |
山东泓瑞医药科技股份公司 |
Procédé de préparation d'amantadine
|
|
WO2024039886A1
(fr)
|
2022-08-19 |
2024-02-22 |
Agenebio, Inc. |
Dérivés de benzoazépine, compositions et méthodes de traitement de déficience cognitive
|